Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Love Pharma Inc ( (TSE:JOLT) ) just unveiled an announcement.
Jolt Health Inc. has appointed Can Partners LLP as its new auditor, with the chartered professional accountants set to serve until the company’s next annual shareholder meeting, subject to ratification. The board of directors and audit committee have approved the change, and accompanying disclosure documents have been filed on the company’s SEDAR+ profile.
The change follows the resignation of former auditor Baker Tilly WM LLP, effective February 17, 2026, whose audit opinions on Jolt’s 2024 and 2025 financial statements were unmodified. The orderly transition, combined with clean prior audit opinions, suggests continuity in the company’s financial reporting framework while introducing a new audit firm to oversee future statements.
More about Love Pharma Inc
Jolt Health Inc. is a life sciences company focused on healthcare, biotechnology and artificial intelligence. It holds exclusive licenses for innovative therapeutic and pharmaceutical products across Europe, the UK and North America, aiming to advance global healthcare through research, collaboration and technology-driven solutions.
Average Trading Volume: 9,281
Technical Sentiment Signal: Sell
Current Market Cap: C$1.59M
See more insights into JOLT stock on TipRanks’ Stock Analysis page.